181 related articles for article (PubMed ID: 26497105)
1. Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance.
Bobeck EN; Ingram SL; Hermes SM; Aicher SA; Morgan MM
Behav Brain Res; 2016 Feb; 298(Pt B):17-24. PubMed ID: 26497105
[TBL] [Abstract][Full Text] [Related]
2. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
[TBL] [Abstract][Full Text] [Related]
3. Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.
Macey TA; Bobeck EN; Hegarty DM; Aicher SA; Ingram SL; Morgan MM
J Pharmacol Exp Ther; 2009 Nov; 331(2):412-8. PubMed ID: 19684256
[TBL] [Abstract][Full Text] [Related]
4. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptor internalization contributes to dermorphin-mediated antinociception.
Macey TA; Ingram SL; Bobeck EN; Hegarty DM; Aicher SA; Arttamangkul S; Morgan MM
Neuroscience; 2010 Jun; 168(2):543-50. PubMed ID: 20394808
[TBL] [Abstract][Full Text] [Related]
6. Lack of Antinociceptive Cross-Tolerance With Co-Administration of Morphine and Fentanyl Into the Periaqueductal Gray of Male Sprague-Dawley Rats.
Bobeck EN; Schoo SM; Ingram SL; Morgan MM
J Pain; 2019 Sep; 20(9):1040-1047. PubMed ID: 30853505
[TBL] [Abstract][Full Text] [Related]
7. Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray.
Meyer PJ; Fossum EN; Ingram SL; Morgan MM
Neuropharmacology; 2007 Jun; 52(8):1580-5. PubMed ID: 17445843
[TBL] [Abstract][Full Text] [Related]
8. Drug dependent sex-differences in periaqueducatal gray mediated antinociception in the rat.
Bobeck EN; McNeal AL; Morgan MM
Pain; 2009 Dec; 147(1-3):210-6. PubMed ID: 19796879
[TBL] [Abstract][Full Text] [Related]
9. Differences in antinociceptive signalling mechanisms following morphine and fentanyl microinjections into the rat periaqueductal gray.
Morgan MM; Tran A; Wescom RL; Bobeck EN
Eur J Pain; 2020 Mar; 24(3):617-624. PubMed ID: 31785128
[TBL] [Abstract][Full Text] [Related]
10. Functionally selective signaling for morphine and fentanyl antinociception and tolerance mediated by the rat periaqueductal gray.
Morgan MM; Reid RA; Saville KA
PLoS One; 2014; 9(12):e114269. PubMed ID: 25503060
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization.
Silva-Moreno A; Gonzalez-Espinosa C; León-Olea M; Cruz SL
Eur J Pharmacol; 2012 Jan; 674(2-3):239-47. PubMed ID: 22079772
[TBL] [Abstract][Full Text] [Related]
12. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
13. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
[TBL] [Abstract][Full Text] [Related]
14. The functional antiopioid action of the ventrolateral periaqueductal gray nociceptin/orphanin FQ and nociceptin receptor system underlies DAMGO analgesic tolerance.
Parenti C; Scoto GM
Pharmacology; 2010; 86(3):138-44. PubMed ID: 20689345
[TBL] [Abstract][Full Text] [Related]
15. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
[TBL] [Abstract][Full Text] [Related]
16. Antagonizing effect of protein kinase C activation on the mu-opioid agonist-induced inhibition of high voltage-activated calcium current in rat periaqueductal gray neuron.
Cho YW; Han SH; Min BI; Rhee JS; Akaike N
Brain Res; 2001 Oct; 916(1-2):61-9. PubMed ID: 11597591
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.
Mehalick ML; Ingram SL; Aicher SA; Morgan MM
J Pain; 2013 Dec; 14(12):1601-10. PubMed ID: 24161274
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.
Fyfe LW; Cleary DR; Macey TA; Morgan MM; Ingram SL
J Pharmacol Exp Ther; 2010 Dec; 335(3):674-80. PubMed ID: 20739455
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia.
Ueda H; Inoue M; Matsumoto T
J Neurosci; 2001 May; 21(9):2967-73. PubMed ID: 11312280
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
Lane DA; Patel PA; Morgan MM
Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
